Mobile

A single-centre, single-blind, randomised, placebo-controlled phase IIa study to investigate the effect of AZD1305 given as an iv infusion on left ventricular performance in patients with left ventric...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001254-41

A single-centre, single-blind, randomised, placebo-controlled phase IIa study to investigate the effect of AZD1305 given as an iv infusion on left ventricular performance in patients with left ventricular dysfunction

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To explore if AZD1305 compromises left ventricular function in patients with left ventricular dysfunction.

Critère d'inclusion

  • Left ventricular function in patient with left ventricular dysfunction

Liens